Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s40545-020-00258-8 http://scihub22266oqcxt.onion/10.1186/s40545-020-00258-8 32968487!7503054!32968487     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32968487&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Pharm+Policy+Pract 2020 ; 13 (?): 61 Nephropedia Template TP {{tp|p=32968487|t=2020. The use of remdesivir outside of clinical trials during the COVID-19 pandemic |pdf=|usr=}}{{32968487}} gab.com Text The use of remdesivir outside of clinical trials during the COVID-19 pandemic JO: J Pharm Policy Pract http://www.kidney.de/pget.php?&tw=1&pmid=32968487 #FOAvip With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antiviral activity in the treatment of this disease. Globally, remdesivir was accessed and investigated through clinical research (clinical trials) and clinical practice (compassionate use, expanded access, early access scheme, and emergency use). Currently, remdesivir approval status differs between states. This paper aims to review and analyze regulatory approaches for accessing and investigating remdesivir, by communicating regulatory variability between countries in terms of terminology, modalities, and protocols. Twit Text FOAVip The use of remdesivir outside of clinical trials during the COVID-19 pandemic ????J Pharm Policy Pract http://www.kidney.de/pget.php?&tw=1&pmid=32968487 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32968487 #FOAvip English Wikipedia <ref>{{Cite pmid|32968487}}</ref> The use of remdesivir outside of clinical trials during the COVID-19 pandemic #MMPMID32968487 Halimi V; Daci A; Ridova N; Panovska-Stavridis I; Stevanovic M; Filipce V; Dimovski A; Grozdanova A J Pharm Policy Pract 2020[]; 13 (?): 61 PMID32968487show ga With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antiviral activity in the treatment of this disease. Globally, remdesivir was accessed and investigated through clinical research (clinical trials) and clinical practice (compassionate use, expanded access, early access scheme, and emergency use). Currently, remdesivir approval status differs between states. This paper aims to review and analyze regulatory approaches for accessing and investigating remdesivir, by communicating regulatory variability between countries in terms of terminology, modalities, and protocols. ?The use of remdesivir outside of clinical trials during the COVID-19 p(epmc).pdf DeepDyve Pubget Overpricing